Cited by 223Intensive Care Unit Cognitive DisordersAlcoholism and Thiamine DeficiencyAnesthesia and Sedative Agents

The DOI matches its Crossref record; 29 of the 30 references it cites were found in a registry or an index.

Benzodiazepines for delirium

Open access
Lonergan, Edmund, Luxenberg, Jay, Areosa Sastre, Almudena·2009·Cochrane Database of Systematic Reviews

Abstract

BACKGROUND: Delirium occurs in 30% of hospitalised patients and is associated with prolonged hospital stay and increased morbidity and mortality. The results of uncontrolled studies have been unclear, with some suggesting that benzodiazepines may be useful in controlling non-alcohol related delirium. OBJECTIVES: To determine the effectiveness and incidence of adverse effects of benzodiazapines in the treatment of non-alcohol withdrawal related delirium. SEARCH STRATEGY: The trials were identified from a search of the Specialized Register of the Cochrane Dementia and Cognitive Improvement Group on 26 February 2008 using the search terms: (deliri* or confusion) and (benzo* or lorazepam," or "alprazolam" or "ativan" or diazepam or valium or chlordiazepam).The CDCIG Specialized Register contains records from major health databases (including MEDLINE, EMBASE, CINAHL, PsycINFO, CENTRAL, LILACS) as well as many ongoing trial databases and grey literature sources. SELECTION CRITERIA: Trials had to be unconfounded, randomized and with concealed allocation of subjects. Additionally, selected trials had to have assessed patients pre- and post-treatment. Where crossover design was present, only data from the first part of the trial were to be examined. DATA COLLECTION AND ANALYSIS: Two reviewers extracted data from included trials. Data were pooled where possible, and were to be analysed using appropriate statistical methods. Odd ratios or average differences were to be calculated. Only "intention to treat" data were to be included. MAIN RESULTS: Only one trial satisfying the selection criteria could be identified. In this trial, comparing the effect of the benzodiazepine, lorazepam, with dexmedetomidine, a selective alpha-2-adrenergic receptor agonist, on delirium among mechanically ventilated intensive care unit patients, dexmedetomidine treatment was associated with an increased number of delirium- and coma-free days compared with lorazepam treated patients (dexmedetomidine patients, average seven days; lorazepam patients, average three days; P = 0.01). One partially controlled study showed no advantage of a benzodiazepine (alprazolam) compared with neuroleptics in treating agitation associated with delirium, and another partially controlled study showed decreased effectiveness of a benzodiazepine (lorazepam), and increased adverse effects, compared with neuroleptics (haloperidol, chlorpromazine) for the treatment of acute confusion. AUTHORS' CONCLUSIONS: No adequately controlled trials could be found to support the use of benzodiazepines in the treatment of non-alcohol withdrawal related delirium among hospitalised patients, and at this time benzodiazepines cannot be recommended for the control of this condition. Because of the scarcity of trials with randomization of patients, placebo control, and adequate concealment of allocation of subjects, it is clear that further research is required to determine the role of benzodiazepines in the treatment of non-alcohol withdrawal related delirium.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/14651858.cd006379.pub3

Cites

29 of 29 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Flagged first, then by citations

Show all 30 references

1 of the 30 references couldn’t be matched to a known paper.

Research works printed but not linked: 6

  1. Adams, 1984, Neuropsychiatric evaluation and treatment of delirium in the critically ill cancer patient, Cancer Bulletin, 36, 156
  2. American Psychiatric Association, 1994, Diagnostic and Statistical Manual of Mental Discorders
  3. Breitbart, 1996, A double-blind trial of haloperidol, chlorpromazine, and lorazepamn in the treatment of delirium in hospitalized AIDS patients, American Journal of Psychiatry, 153, 231, 10.1176/ajp.153.2.231 · DOI
  4. Luxenberg, 1996, Delirium in the elderly
  5. McCusker, 2001, Delirium in older medical inpatients. Marker for subsequent cognitive and functional status, Canadian Medical Association Journal, 165, 575
  6. The World Health Organization, 1993, The ICD-10 Classification of Mental and Behavioral Disorders: Diagnostic Criteria for Research

Cited by

Sorted by citations

Metadata

Authors
Lonergan, E., Luxenberg, J., & Areosa Sastre, A.
Affiliations
  • 4 Captain Drive Apt 215 Emeryville CA USA 94608
  • Jewish Home (US)
  • c/ Mauricio Legendre 17, 5-A Madrid Spain 28046
Venue
Cochrane Database of Systematic Reviews
Publisher
Wiley
Published
2009-10-07
Volume
2010
Issue
1
Pages
CD006379-CD006379
ISSN
  • 1361-6137 (ISSN-L)
  • 1465-1858
OpenAlex
W1903577601
Cited by
223
References
30
Citations by year
2026: 5 · 2025: 4 · 2024: 3 · 2023: 2 · 2022: 6 · 2021: 6 · 2020: 41 · 2019: 14 · 2018: 12 · 2017: 12 · 2016: 11 · 2015: 17 · 2014: 16 · 2013: 19 · 2012: 22
FWCI
2.42
Type
journal article
Language
en
Open access
Locations
  • Cochrane Database of Systematic Reviews (publishedVersion)
  • Europe PMC (PubMed Central) (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Critical Care and Intensive Care Medicine › Intensive Care Unit Cognitive Disorders
  • Health Sciences › Medicine › Clinical Neurology › Alcoholism and Thiamine Deficiency
  • Health Sciences › Medicine › Anesthesiology and Pain Medicine › Anesthesia and Sedative Agents
Keywords
delirium, benzodiazepines, lorazepam, dexmedetomidine, alprazolam, antipsychotic drugs, haloperidol, chlorpromazine, agitation, mechanical ventilation, intensive care unit patients, adverse effects, treatment effectiveness, hospitalized patients, benzodiazepine withdrawal
MeSH terms
Benzodiazepines, Delirium, Humans, Lorazepam, Dexmedetomidine

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review